Grail [GRAL] vs Danaher [DHR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Grail wins in 5 metrics, Danaher wins in 12 metrics, with 0 ties. Danaher appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGrailDanaherBetter
P/E Ratio (TTM)-1.0345.65Grail
Price-to-Book Ratio1.022.94Grail
Debt-to-Equity Ratio2.6935.45Grail
PEG Ratio0.01-1.22Danaher
EV/EBITDA-4.4022.54Grail
Profit Margin (TTM)-62.12%14.21%Danaher
Operating Margin (TTM)-368.15%20.12%Danaher
EBITDA Margin (TTM)N/A20.12%N/A
Return on Equity-17.68%6.68%Danaher
Return on Assets (TTM)-11.81%4.01%Danaher
Free Cash Flow (TTM)$-582.36M$5.30BDanaher
1-Year Return402.99%-20.38%Grail
Price-to-Sales Ratio (TTM)17.606.41Danaher
Enterprise Value$1.79B$169.55BDanaher
EV/Revenue Ratio13.357.06Danaher
Gross Profit Margin (TTM)-50.01%59.35%Danaher
Revenue per Share (TTM)$4$33Danaher
Earnings per Share (Diluted)$-11.71$4.71Danaher
Beta (Stock Volatility)N/A0.80N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Grail vs Danaher Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Grail1.26%31.45%102.16%40.28%163.42%265.74%
Danaher2.22%16.31%7.80%5.80%8.64%-6.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Grail402.99%348.29%348.29%348.29%348.29%348.29%
Danaher-20.38%-9.67%7.28%261.39%672.79%1,102.40%

News Based Sentiment: Grail vs Danaher

Grail

News based Sentiment: POSITIVE

Despite a slight earnings miss, Grail experienced strong revenue growth, positive analyst upgrades, and increased institutional investment in October. The upcoming presentation of the PATHFINDER 2 study results represents a significant catalyst for the company's future, making this a noteworthy month for investors.

View Grail News Sentiment Analysis

Danaher

News based Sentiment: MIXED

Danaher delivered a mixed month, with strong Q2 results and positive developments in AI and potential tariff benefits offset by challenges in the Life Sciences segment and differing analyst opinions. The company's overall outlook remains positive, but investors should monitor key areas for potential risks and opportunities.

View Danaher News Sentiment Analysis

Performance & Financial Health Analysis: Grail vs Danaher

MetricGRALDHR
Market Information
Market Cap i$2.36B$153.94B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,216,1935,958,360
90 Day Avg. Volume i879,3644,345,910
Last Close$65.54$214.99
52 Week Range$12.33 - $73.74$171.00 - $279.41
% from 52W High-11.11%-23.06%
All-Time High$73.74 (Oct 03, 2025)$296.06 (Sep 06, 2021)
% from All-Time High-11.12%-27.38%
Growth Metrics
Quarterly Revenue Growth0.11%0.03%
Quarterly Earnings Growth0.11%-0.39%
Financial Health
Profit Margin (TTM) i-0.62%0.14%
Operating Margin (TTM) i-3.68%0.20%
Return on Equity (TTM) i-0.18%0.07%
Debt to Equity (MRQ) i2.6935.45
Cash & Liquidity
Book Value per Share (MRQ)$64.21$73.10
Cash per Share (MRQ)$16.72$4.13
Operating Cash Flow (TTM) i$-370,048,000$6.17B
Levered Free Cash Flow (TTM) i$-142,499,120$3.88B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Grail vs Danaher

MetricGRALDHR
Price Ratios
P/E Ratio (TTM) i-1.0345.65
Forward P/E i-5.5825.66
PEG Ratio i0.01-1.22
Price to Sales (TTM) i17.606.41
Price to Book (MRQ) i1.022.94
Market Capitalization
Market Capitalization i$2.36B$153.94B
Enterprise Value i$1.79B$169.55B
Enterprise Value Metrics
Enterprise to Revenue i13.357.06
Enterprise to EBITDA i-4.4022.54
Risk & Other Metrics
Beta iN/A0.80
Book Value per Share (MRQ) i$64.21$73.10

Financial Statements Comparison: Grail vs Danaher

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GRALDHR
Revenue/Sales i$31.84M$5.74B
Cost of Goods Sold i$51.77M$2.23B
Gross Profit i$-19.93M$3.51B
Research & Development i$53.63M$379.00M
Operating Income (EBIT) i$-153.61M$1.27B
EBITDA i$-114.33M$1.87B
Pre-Tax Income i$-146.41M$1.13B
Income Tax i$-40.20M$175.00M
Net Income (Profit) i$-106.21M$954.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GRALDHR
Cash & Equivalents i$133.90M$1.99B
Total Current Assets i$727.66M$9.53B
Total Current Liabilities i$74.98M$6.65B
Long-Term Debt i$51.34M$15.98B
Total Shareholders Equity i$2.41B$50.86B
Retained Earnings i$-9.91B$44.91B
Property, Plant & Equipment i$126.94MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GRALDHR
Operating Cash Flow i$-88.63M$1.47B
Capital Expenditures i$-62,000$-239.00M
Free Cash Flow i$-95.07M$1.05B
Debt Repayment iN/AN/A
Common Stock Repurchase iN/A$-1.08B

Short Interest & Institutional Ownership Analysis

MetricGRALDHR
Shares Short i4.47M9.53M
Short Ratio i6.442.85
Short % of Float i0.14%0.01%
Average Daily Volume (10 Day) i1,216,1935,958,360
Average Daily Volume (90 Day) i879,3644,345,910
Shares Outstanding i33.89M719.10M
Float Shares i24.18M637.13M
% Held by Insiders i0.14%0.11%
% Held by Institutions i0.74%0.83%

Dividend Analysis & Yield Comparison: Grail vs Danaher

MetricGRALDHR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A